Search the Newsreel

AMAT Shares Surge After-Hours On Blowout Earnings — CEO Says Global Semiconductor Industry Revenues To Hit $1T In 2026

How Investors Are Reacting To Aurinia Pharmaceuticals (AUPH) Extended Voclosporin Exclusivity And Share Buyback

Aurinia Pharmaceuticals Inc. recently reported second-quarter 2026 results showing higher revenue and earnings year over year, reiterated its 2026 revenue and net product sales guidance, completed a large share buyback program, and finalized a settlement with Teva Pharmaceuticals that delays U.S. generic voclosporin entry …

Crompton Greaves targets 13-14% revenue CAGR, ₹8,096 crore FY26 top line

Gulshankumar Chopra acquires 49.82% stake in Niraj Cement Structurals

Applied Materials’s Q2 Earnings Call: Our Top 5 Analyst Questions

Applied Materials reported strong Q2 results, exceeding revenue and profitability estimates, driven by robust demand for semiconductor manufacturing equipment. Despite the positive performance and increased guidance for Q3, the market reacted negatively. The article highlights key analyst questions from the earnings call, focusing on …

Rajshree Sugars & Chemicals Ltd. (RAJSREESUG) Share Price Rises 8.99% Today

Indo Borax & Chemicals Ltd. Share Price Today Gains 10.15%

Precious Metals Stocks Rally Broadly, Wheaton Precious Metals’ Low-Cost Model Stands Out

Precious metals stocks, including Wheaton Precious Metals (WPM), rallied sharply due to a U.S. Treasury Department announcement to expand long-term bond buybacks, which decreased bond yields and increased the appeal of non-yielding assets like gold. Wheaton Precious Metals, a metal streaming company, saw its …

Kothari Sugars And Chemicals Ltd. Share Price Up 13.34%

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Receives Average Rating of "Moderate Buy" from Analysts

Thirteen research firms have given Syndax Pharmaceuticals (NASDAQ:SNDX) an average recommendation of "Moderate Buy," with an average 12-month price target of $41.91. Despite missing Q2 earnings and revenue estimates and insider share sales, institutional investors like BlackRock and Vanguard have increased their stakes. The …

Phio Pharmaceuticals (PHIO) Chairman Robert Bitterman Buys 10,00

Phio Pharmaceuticals (PHIO) Chairman Robert Bitterman has purchased an additional 10,000 shares of the company, bringing his total holdings to 431,421 shares. This transaction at $1.06 per share reflects a strong insider sentiment, with 6 insider buys and 0 insider sells over the past …

Intercontinental Hotels Group (NYSE:IHG) Stock Price Passes Above Two Hundred Day Moving Average - Here's What Happened

Intercontinental Hotels Group (NYSE:IHG) shares have surpassed their 200-day moving average, trading at $161.5050 after reaching a high of $163.00. The stock maintains a "Moderate Buy" consensus rating with an average price target of $174.50, despite mixed analyst views including a recent downgrade to …

REGN Stockholders Interested in Leading the Class Action Against Regeneron Pharmaceuticals, Inc. Should Contact Robbins LLP for Information About Recovering Their Losses

Robbins LLP is reminding investors that a securities class action lawsuit has been filed against Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN). The lawsuit alleges that Regeneron misled investors about its Phase 3 Fianlimab-Libtayo clinical trial for advanced melanoma, specifically regarding statistical assumptions and clinical differentiation. …

Syndax (SNDX) Quarterly Results: Profit Per Share Falls Below Its Benchmark in the Reported Period; Trading Move

Lincoln (LNC) Quarterly Results: EPS Beats Its Estimate; Share Response: Shares Move 3.55% Lower in Latest Trading - Full Year Guidance

Medallion Metals to Raise AU$60 Million Through Placement; Shares Gain 4%

Huntington Ingalls Industries Inc. stock underperforms Thursday when compared to competitors

Shares of Huntington Ingalls Industries Inc. (HII) fell by 3.32% on Thursday, closing at $301.40. This decline occurred during a broader market downturn, with the S&P 500 Index and Dow Jones Industrial Average also experiencing losses. This marks the fourth consecutive day of losses …

Applied Materials Delivered a Record Quarter. The Stock Fell Anyway

Applied Materials (AMAT) reported a record fiscal third quarter with revenue up 25% year-over-year and EPS up 41%, exceeding analyst expectations. Despite strong performance and an optimistic outlook driven by AI demand, the stock fell over 3% after-hours, likely due to its "priced for …

Why Regeneron (REGN) Is Up 5.4% After FDA Approves Pasatru For Ultra-Rare FOP Therapy

In August 2026, Regeneron Pharmaceuticals announced that the US FDA approved Pasatru (garetosmab-grts) to reduce new heterotopic ossification lesions and flare-ups in adults with fibrodysplasia ossificans progressiva, based on positive Phase 3 OPTIMA trial results. This approval adds a rare-disease monoclonal antibody to Regeneron's …

Air Products (APD) Stock Looks Fully Priced Despite A 14% Fair Value Gap

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Air Products and Chemicals has delivered a 27.8% total return over the past five …

Xeris (XERS) Financial Results: EPS Does Not Reach the Reported Estimate in the Available Record; Price Move

What Is Shaping Dalaroo Metals (ASX:DAL) on Placement?

WillScot (WSC) Results at a Glance: EPS Clears the Reported Estimate in the Latest Session; Post-Report: Shares Close 1.05% Lower on the Day - Financial Summary

Telix Pharmaceuticals Limited 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:TLX) 2026-08-20

KM Sugar Mills Consolidated June 2026 Net Sales at Rs 189.93 crore, down 8.79% Y-o-Y

Regeneron (REGN) Stock Looks Undervalued On Expanded Cancer Collaboration News

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Regeneron Pharmaceuticals stock has delivered a 43.0% return over the past year, yet the …

Pivotal Metals (ASX:PVT) Expands Belleterre Copper-Nickel-PGM Footprint With Bambino Acquisition

Titan Minerals (ASX:TTM) Shares Jump as New Gold Discovery Returns 33.5m at 6.6 g/t

Glenmark Pharmaceuticals gains 1.4% after US FDA nod for Fluticasone nasal spray

Mirum Pharmaceuticals(MIRM.US) Officer Sells US$4 Million in Common Stock

A Mirum Pharmaceuticals officer recently sold common stock valued at approximately $4 million. This transaction indicates a significant insider sale at the company.

We're Keeping An Eye On Titan Minerals' (ASX:TTM) Cash Burn Rate

Imperial Metals (TSX:III) Shares Climbed, What Is Driving Attention Today?

Daily Special: Etherstack, Genesis Resources, Pivotal Metals, Latitude 66, Many Peaks Minerals

What Does FLSmidth (CPSE:FLS) Gain From Its New Service Business Chief?

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. FLSmidth (CPSE:FLS) has appointed Petri Virrankoski as President of its Service Business Line. Virrankoski brings experience in turnaround, growth, profitability and operational improvement …

Amylyx Pharmaceuticals Announces Pricing of an Upsized $500 Million Underwritten Public Offering of Common Stock

Amylyx Pharmaceuticals has announced the pricing of an upsized underwritten public offering of 14,090,000 shares of its common stock at $35.50 per share, aiming to raise $500.2 million before deductions. The company plans to use the net proceeds for pre-commercial activities for avexitide, research …

Form 144(Amend) | Aura Minerals(AUGO.US) Insider Proposes to Sell 4.68 Million in Common Stocks

An insider at Aura Minerals (AUGO.US) has proposed to sell 4.68 million common stocks, as indicated by a Form 144(Amend) filing. This type of filing suggests a planned sale of restricted or control securities. The proposed sale involves a significant number of shares, which …